GGrantIndex
← Leaderboards

Mats Ljungman

University Of Michigan At Ann Arbor

$9,091,730
Attributed
$10,710,028
Total exposure
15
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,710,028 · 15

By mechanism

R01$5,334,555 · 4
UM1$2,337,229 · 1
P50$1,271,844 · 2
R21$1,178,275 · 3
P30$522,125 · 1
U13$36,000 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsTechnologyApplications GrantsIn VivoInterestIonizing RadiationCancer CellResearch PersonnelTumorRadiationGrantResponseMalignant NeoplasmsPre-ClinicalCell LineFundingFosteringIn VitroProgramsBaseMemberGenomeDna RepairTissues

Grant awards (48)

Precision targeting of bladder cancer using CRISPR$568,773
R01 · FY2025 · CA · contact PI
Career Enhancement Program$93,888
P50 · FY2025 · CA · contact PI
Precision targeting of bladder cancer using CRISPR$566,310
R01 · FY2024 · CA · contact PI
Career Enhancement Program$90,132
P50 · FY2024 · CA · contact PI
Targeting the RNA Exosome for Cancer Therapeutics$479,616
R01 · FY2023 · CA · contact PI
Career Enhancement Program$95,694
P50 · FY2023 · CA · contact PI
Targeting the RNA Exosome for Cancer Therapeutics$479,616
R01 · FY2022 · CA · contact PI
Precision targeting of bladder cancer using CRISPR technology$214,414
R21 · FY2022 · CA · contact PI
Experimental Irradiation (EI)$97,185
P30 · FY2022 · CA · contact PI
Targeting the RNA Exosome for Cancer Therapeutics$489,405
R01 · FY2021 · CA · contact PI
Mapping of Novel Candidate Functional Elements with Bru-Seq Technology$460,492
UM1 · FY2021 · HG · contact PI
Precision targeting of bladder cancer using CRISPR technology$182,325
R21 · FY2021 · CA · contact PI
Experimental Irradiation (EI)$98,996
P30 · FY2021 · CA · contact PI
Targeting the RNA Exosome for Cancer Therapeutics$489,405
R01 · FY2020 · CA · contact PI
Mapping of Novel Candidate Functional Elements with Bru-Seq Technology$466,080
UM1 · FY2020 · HG · contact PI
Experimental Irradiation (EI)$98,996
P30 · FY2020 · CA · contact PI
Targeting the RNA Exosome for Cancer Therapeutics$489,405
R01 · FY2019 · CA · contact PI
Mapping of Novel Candidate Functional Elements with Bru-Seq Technology$466,080
UM1 · FY2019 · HG · contact PI
Experimental Irradiation (EI)$98,998
P30 · FY2019 · CA · contact PI
Mapping of Novel Candidate Functional Elements with Bru-Seq Technology$464,835
UM1 · FY2018 · HG · contact PI
Experimental Irradiation (EI)$98,943
P30 · FY2018 · CA · contact PI
Experimental Irradiation (EI)$9,970
P30 · FY2018 · CA · contact PI
Experimental Irradiation (EI)$8,973
P30 · FY2018 · CA · contact PI
Experimental Irradiation (EI)$7,663
P30 · FY2018 · CA · contact PI
Experimental Irradiation (EI)$2,401
P30 · FY2018 · CA · contact PI
Mapping of Novel Candidate Functional Elements with Bru-Seq Technology$479,742
UM1 · FY2017 · HG · contact PI
2013 Environmental Mutagen Society Annual Meeting$12,000
U13 · FY2015 · ES · contact PI
Development and Validation of BruChase-Seq and BrUV-Seq$382,295
R01 · FY2014 · HG · contact PI
2013 Environmental Mutagen Society Annual Meeting$12,000
U13 · FY2014 · ES · contact PI
Travel Awards for the 4th Asian Conference on Environmental Mutagens$10,000
R13 · FY2014 · ES · contact PI
Development and Validation of BruChase-Seq and BrUV-Seq$372,543
R01 · FY2013 · HG · contact PI
Mechanisms of Genotoxic Stress-regulated Gene Expression in Human Cells$190,488
R21 · FY2013 · ES · contact PI
2013 Environmental Mutagen Society Annual Meeting$12,000
U13 · FY2013 · ES · contact PI
Development and Validation of BruChase-Seq and BrUV-Seq$390,097
R01 · FY2012 · HG · contact PI
Mechanisms of Genotoxic Stress-regulated Gene Expression in Human Cells$233,250
R21 · FY2012 · ES · contact PI
Environmental Mutagen Society 2012 Annual Meeting-Trainee and Speaker Support$14,000
R13 · FY2012 · ES · contact PI
Targeting ATDC with PARP inhibitors in pancreatic cancer$193,335
R21 · FY2011 · CA · contact PI
Targeting ATDC with PARP inhibitors in pancreatic cancer$164,463
R21 · FY2010 · CA · contact PI
11th Annual Midwest DNA Repair Symposium$6,000
R13 · FY2009 · ES · contact PI
REGULATION OF P53 STABILITY BY SER315 PHOSPHORYLATION$215,009
R01 · FY2002 · CA
BUTYRATE ON APOPTOSIS INDUCED BY RADIATION, HORMONE WITHDRAWAL AND CHEMOTHERAPY$165,355
P50 · FY2002 · CA
REGULATION OF P53 STABILITY BY SER315 PHOSPHORYLATION$208,745
R01 · FY2001 · CA
BUTYRATE ON APOPTOSIS INDUCED BY RADIATION, HORMONE WITHDRAWAL AND CHEMOTHERAPY$165,355
P50 · FY2001 · CA
REGULATION OF P53 STABILITY BY SER315 PHOSPHORYLATION$203,336
R01 · FY2000 · CA
BUTYRATE ON APOPTOSIS INDUCED BY RADIATION, HORMONE WITHDRAWAL AND CHEMOTHERAPY$165,355
P50 · FY2000 · CA
BUTYRATE ON APOPTOSIS INDUCED BY RADIATION, HORMONE WITHDRAWAL AND CHEMOTHERAPY$165,355
P50 · FY2000 · CA
BUTYRATE ON APOPTOSIS INDUCED BY RADIATION, HORMONE WITHDRAWAL AND CHEMOTHERAPY$165,355
P50 · FY2000 · CA
BUTYRATE ON APOPTOSIS INDUCED BY RADIATION, HORMONE WITHDRAWAL AND CHEMOTHERAPY$165,355
P50 · FY2000 · CA